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The amino acid leucine causes an increase of collagen α1(I) synthesis in hepatic stellate cells through the activation of translational regulatory
mechanisms and PI3K/Akt/mTOR and ERK signaling pathways. The aim of the present study was to evaluate the role played by reactive oxygen
species on these effects. Intracellular reactive oxygen species levels were increased in hepatic stellate cells incubated with leucine 5 mM at early
time points, and this effect was abolished by pretreatment with the antioxidant glutathione. Preincubation with glutathione also prevented 4E-BP1,
eIF4E and Mnk-1 phosphorylation induced by leucine, as well as enhancement of procollagen α1(I) protein levels. Inhibitors for MEK-1
(PD98059), PI3K (wortmannin) or mTOR (rapamycin) did not affect leucine-induced reactive oxygen species production. However, preincubation
with glutathione prevented ERK, Akt and mTOR phosphorylation caused by treatment with leucine. The mitochondrial electron chain inhibitor
rotenone and the NADPH oxidase inhibitor apocynin prevented reactive oxygen species production caused by leucine. Leucine also induced an
increased phosphorylation of IR/IGF-R that was abolished by pretreatment with either rotenone or apocynin. Therefore, leucine exerts on hepatic
stellate cells a prooxidant action through NADPH oxidase and mitochondrial Reactive oxygen species production and these effects mediate the
activation of IR/IGF-IR and signaling pathways, finally leading to changes in translational regulation of collagen synthesis.
© 2007 Elsevier B.V. All rights reserved.Keywords: Leucine; Hepatic stellate cells; Type I collagen; Translational regulation; Oxidative stress1. Introduction
Reactive oxygen species (ROS) generated in the cell as a
consequence of oxygen-based metabolism were initially con-
sidered as harmful derivatives that in some instances could be
used for the defense of the cell. In the last years, however,
growing evidence of regulation of different cell functions by
moderate levels of ROS have lead to the concept of these
molecules acting like secondary messengers with active roles inAbbreviations: HSC, hepatic stellate cells; ROS, reactive oxygen species;
eIF4E, eukaryotic initiation factor 4E; mTOR, mammalian target of rapamycin;
PI3K, phosphatidyl inositol 3 kinase; ERK, extracellular-regulated kinase;
MAPK, mitogen-activated protein kinase; GSH, glutathione (reduced form);
NAC, N-acetylcysteine
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doi:10.1016/j.bbamcr.2007.07.005signaling processes. One of the facts that support this view is the
increased ROS production found in response to a wide range of
agents, from inflammatory cytokines like TNF-α [1] to
hormones or growth factors like insulin [2], EGF [3], PDGF
[4] or TGF-β [5]. Moreover, inhibition of oxidative stress
generation by the addition of antioxidants usually prevents the
effects of the agonist, indicating that ROS are indeed key me-
diators of specific signaling events. Among other effects, ROS
have been shown to modulate signal transduction through the
inhibition of protein phosphatases, a family of redox-sensitive
enzymes [6].
The precise mechanism(s) through which intracellular ROS
are generated in response to extracellular signals is in most
cases not fully established and seems to be of different nature
depending on the agent and the cell type involved. In general
terms, oxidative stress can be caused either by the inhibition of
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expression of antioxidant enzymes, or by direct activation of
ROS production. The main sources of ROS are the
mitochondria, that generates superoxide radical (O2·−) as a
result of defective electron transfer, and the NADPH oxidase
complex that was initially described in phagocytic cells but
has been recently characterized in many cell types as an non-
phagocytic complex that constitutively produces basal ROS
levels [7].
Liver fibrosis is a pathophysiological condition that has
been extensively related to oxidative stress. Many experimen-
tal data demonstrate that ROS accumulate in the injured liver
and mediate cellular and molecular events that contribute to
the development of liver fibrosis. Most importantly, ROS
participate in the activation and fibrogenic effects of hepatic
stellate cells (HSC), the main source of extracellular matrix
proteins in the fibrotic liver [8]. Studies carried out in cell
culture models have shown that the responses elicited by ROS
in HSC range from necrotic or apoptotic cell death to up-
regulation of collagen production, depending on the proox-
idant agent employed and the localization and extent of
oxidative-stress [9]. Moreover, oxidative stress caused either
by prooxidant agents or by profibrogenic cytokines like TGF-
β has also been shown to modulate intracellular signaling
pathways in HSC, including ERK and Akt activation, and to
regulate collagen synthesis at translational and post-transla-
tional levels [10–13].
We have previously shown that leucine, an essential amino
acid that is also a nutritional signal, exerts profibrogenic actions
on HSC, inducing collagen I protein synthesis through the
activation of signaling pathways and the modulation of
translational regulatory steps [14]. The aim of the present
paper was to study the possible role played by oxidative stress as
a mediator of leucine effects in HSC, and to establish the
molecular mechanisms involved.
2. Materials and methods
2.1. Reagents
Leucine, glutathione (GSH), N-acetylcysteine (NAC), menadione, rapamy-
cin, lucigenin, apocynin and rotenone were from Sigma Chemical Company (St.
Louis, MO). Cell culture reagents were from Gibco BRL (Grand Island, NY).
2′,7′-dichlorofluorescein diacetate (DCFA-DA) was from Molecular Probes
(Eugene, OR). Wortmannin and PD098059 were purchased from Calbiochem®
(Germany).
2.2. Cell culture and treatment
The experiments were carried out using the rat HSC line CFSC-2G. This
non-tumoral cell line was obtained after spontaneous immortalization in
culture of HSC isolated from a CCl4-cirrhotic liver [15] and is characterized
by low basal levels of expression of type I collagen genes and by the presence
of mRNA for nestin and α-SMA [16]. Therefore, it can be considered as a
‘‘transitional’’ HSC, in which the activation process is already initiated. Cells
were cultured in minimum essential medium (MEM) supplemented with 10%
bovine fetal serum and non-essential amino acids for 36 h. The medium was
replaced for serum-free MEM for 12 h, after which treatments were carried
out. Unless otherwise indicated, HSC were treated with leucine 5 mM. In
some experiments either GSH (2 mM), NAC (5 mM), menadione (100 μM),PD098059 (10 μM), wortmannin (200 nM), apocynin (10 μM) or rotenone
(20 μM) were added 30 min before treating the cells with leucine. Rapamycin
(100 nM) was added 2 h before treatment with leucine.
2.3. Western blot
For Western blot analysis 6×105 cells were seeded on 60 mm culture
dishes. After treatment proteins were extracted in Triton ice-cold buffer
containing 1% Triton X-100, 150 mM NaCl, 50 mM Tris–HCl pH 8.0, 0.1%
SDS, 1 mM EDTA, 1 mM PMSF, 0.1 mM DTT and 1 μg/ml aprotinin. Protein
concentration of the samples was determined by BCA (bicinchoninic acid
assay). For immunoblotting assay, equal amounts of protein (30 μg) were
electrophoresed on polyacrilamide gels and proteins were electrophoretically
transferred on nitrocellulose membranes (BioRad, Hercules, CA). Membranes
were incubated with a blocking solution at room temperature and with specific
primary antibodies at 4 °C overnight. Antibodies against total 4E-BP1,
phospho-specific eIF4E, phospho-specific and total Akt, phospho-specific and
total mTOR, phospho-specific ERK, phospho-specific Mnk-1 and phospho IR/
IGF-IR were purchased from Cell Signalling Technology (Beverly, MA).
Antibody against total ERK was from Santa Cruz Biotechnology (Santa Cruz,
CA). Anti β-actin antibody was from Sigma. Membranes were also incubated
with an antibody raised against human collagen type I (Rockland, Inc.,
Rockland, PA). After incubation with primary antibodies, membranes were
washed and incubated with the secondary polyclonal (BioRad, Hercules, CA)
or monoclonal (Amersham Life Science, Arlington Heights, IL) antibody,
conjugated to horseradish peroxidase. Immunoreactive proteins were detected
by enhanced chemiluminescence system (ECL; Roche Molecular Biochem-
icals, Lewes, United Kingdom). Figures are representative of at least three
independent experiments.
2.4. Measurement of ROS
Production of ROS, mainly peroxides, was measured using the fluorescent
probe CM-H2DCFDA. CM-H2DCFDA is freely permeable across cell
membranes and is incorporated into hydrophobic lipid regions of the cell.
H2O2 produced by the cell oxidizes H2DCF-DA to 2,7-dichlorofluorescein
(DCF), the fluorescence of which is proportional to the H2O2 produced. The
excitation and emission wavelengths for DCFDAwere 485 nm and 530 nm. For
time-course studies HSC were plated to subconfluence in 60 mm culture dishes
and treated with 5 mM leucine for time points ranging from 5 min to 4 h. Short-
time image analysis was performed by fluorescence microscopy. Cells were
loaded for 20 min with 10 μM CM-H2DCFDA at 37 °C in the dark prior the
treatment with the amino acid. Data from long time experiments were
performed in a Cytofluor 2350 (Millipore). Dose–response studies were carried
out treating HSC for 1 h with different concentrations of leucine (1–7.5 mM).
When indicated, HSC were pretreated with inhibitors for signaling pathways or
with GSH, rotenone or apocynin in the above described conditions. Values are
means±SD of at least triplicate data from four independent experiments.
2.5. Superoxide detection
Measurement of intracellular superoxide anion (O2·−) production was
carried out using lucigenin enhanced chemiluminescence assay. This method is
based on the reaction between reduced lucigenin and O2·−, resulting in the
emission of photons that can be quantified using a luminometer. HSC were
cultured in 60 mm Petri dishes and serum starved for 12 h. Cells were treated
with leucine 5 mM for 5 or 40 min and then washed and transferred into a
cuvette in 1 ml PBS. Cellular suspensions were loaded into the luminometer and
lucigenin at 250 μM was injected. The readings were recorded 5 min later.
2.6. Statistical analysis
Data were analyzed using the Kruskal–Wallis test to determine differences
between all independent groups. When significant differences were obtained
( pb0.05), differences between two groups were tested using theMann–Whitney
U test.
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3.1. Leucine induces ROS production in HSC
The effect caused by leucine on intracellular levels of reactive
oxygen species (ROS) was studied using the fluorescent probe
CM-H2DCFDA, which reacts mainly with hydrogen peroxide
and to a lesser extent with other ROS. Fluorescent microscopy
analysis demonstrated that HSC incubated with leucine 5 mM
for 5 or 60 min presented an increased fluorescence compared to
untreated cells (Fig. 1A). Fluorimetric assays at later incubation
time periods showed that ROS reached maximum levels by 1
h of treatment with leucine 5 mM, and decreased to basal levels
after 2 h (Fig. 1B). Dose–response experiments were carried out
incubating HSC for 1 h with different concentrations of leucine,
ranging from 1 to 7.5 mM. As shown in Fig. 1C, ROS levels
increased in a dose-dependent fashion (Fig. 1C). ROS
accumulation induced by 5 mM leucine was similar to that
obtained by incubation of HSC with 100 μM menadione, and
was prevented by pretreatment with either 2 mM of the
intracellular antioxidant glutathione (reduced form, GSH), or
5 mM of its precursor N-acetylcysteine (Fig. 1D).Fig. 1. Measurement of ROS production in HSC treated with leucine. Intracellular R
microscopy analysis of ROS production in HSC treated with leucine 5 mM. (B) Time
ROS levels in HSC treated for 1 h with different concentrations of leucine. Each bar
least triplicate data from four independent experiments. (⁎⁎pb0.01, vs. control; n.s.,
either GSH 2 mM or NAC 5 mM and treated for 1 h with leucine 5 mM. The prooxid
the mean±SD of fluorescence fold change compared to controls of at least triplicate d
treated cells; n.s., not significant).3.2. ROS mediate the effects of leucine on procollagen α1(I)
levels and translation regulatory steps
Once the prooxidant action of leucine was established, we
studied the role played by ROS on the effects caused by this
amino acid in HSC. Leucine had been shown to induce
procollagen α1(I) production in HSC through the activation
of translational regulatory steps: 4E-BP1 and eIF4E phos-
phorylation. Hyperphosphorylation of 4E-BP1 leads to an
induction of protein synthesis through the release of eIF4E, a
translation initiation factor that binds to the 5´ end of mRNA
and is required to form the eIF4F complex. Phosphorylation
of eIF4E can also result in enhanced protein synthesis, since
it facilitates the formation of the translation initiation
complex. Mnk-1, a soluble kinase which is activated by
ERK independently of 4E-BP1 modification, is responsible
for eIF4E phosphorylation induced by leucine [14].
To determine whether ROS accumulation mediates these
effects, HSC were pretreated with 2 mM GSH before the
addition of leucine 5 mM, and the phosphorylated forms for 4E-
BP1 and eIF4E, as well as procollagen α1(I) levels were
analyzed by Western blot. GSH pretreatment abolished theOS levels were determined using CM-H2DCFDA as a probe. (A) Fluorescent
course analysis of ROS levels determined by fluorimetric assay. (C) Intracellular
represents the mean±SD of fluorescence fold change compared to controls of at
not significant). (D) Intracellular ROS levels in HSC pretreated for 30 min with
ant menadione (100 μM, 1 h) was used as a positive control. Each bar represents
ata from four independent experiments. (⁎⁎pb0.01, a, vs. control; b, vs. leucine-
Fig. 2. Effect of GSH on 4E-BP1 and eIF4E phosphorylation and procollagenα1(I)
levels induced by leucine. Cells were pretreated with 2 mM GSH and treated with
leucine 5mM either for 2 h (for the detection of 4E-BP1 and eIF4E), or 48 h (for the
detection of procollagen α1(I)), and protein levels were analyzed by Western blot.
The phosphorylated form of eIF4E was detected using a phospho-specific antibody
against the protein. 4E-BP1 resolved into three bands on SDS polyacrylamide gels,
with the top band (γ-band) corresponding to the hyperphosphorylated form of the
protein.
Fig. 4. Role of oxidative stress on signaling pathways activated by leucine in
HSC. Cells were incubated for 30 min with GSH 2 mM before adding leucine
5 mM for the indicated times, and protein levels were analyzed by Western blot.
(A) Effect of GSH on ERK, Mnk-1 and Akt phosphorylation in HSC treated
with leucine for 15 and 30 min. (B) Effect of GSH on mTOR phosphorylation
levels in HSC treated with leucine for 5 and 30 min. Data of phosphorylation
fold change are included.
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BP1 and eIF4E phosphorylation induced by leucine in HSC. The
effects of GSH on 4E-BP1 and eIF4E correlated with decreased
procollagen α1(I) protein levels in HSC pretreated with GSH
and treated for 48 h with leucine (Fig. 2).
3.3. The activation of PI3K/Akt/mTOR and ERK in response to
leucine is mediated by ROS accumulation
We had previously demonstrated that in HSC leucine
activates PI3K/Akt/mTOR and ERK, leading to increased
translation of procollagen α1(I). To determine whether these
signaling pathways were involved in increased ROS production
caused by leucine, pharmacological inhibitors for ERK (MEK-1
inhibitor, PD098059), PI3K (wortmannin) or mTOR (rapamy-
cin) were added prior to treatment with leucine, and ROS levels
analyzed as above. Pretreatment of HSC with the inhibitors didFig. 3. Effect of signaling pathways inhibitors on intracellular ROS levels induced
by leucine. HSC were pretreated for 30 min with 10 μM PD098059 (MEK-1
inhibitor), or 200 nM wortmannin (PI3K inhibitor), or for 2 h with 100 nM
rapamycin (mTOR inhibitor) prior incubationwith leucine 5mMfor 1 h. ROS levels
were analyzed by fluorimetry using CM-H2DCFDA as a probe. Each bar represents
the mean±SD of fluorescence fold change compared to controls of at least triplicate
data from four independent experiments. (⁎⁎pb0.01, vs. control; n.s., not
significant).not prevent the effect of leucine on intracellular ROS levels,
suggesting that these enzymes were activated either indepen-
dently or downstream of ROS production (Fig. 3).
The possibility of ROS generation being upstream of
signaling pathways activated by leucine was then studied
using GSH as an antioxidant and evaluating its effects on
leucine-treated HSC. ERK, Mnk-1 and Akt phosphorylation
levels were analyzed by Western blot in HSC pretreated with
GSH and treated with leucine. GSH prevented the effect of
leucine on phosphorylation levels of all the enzymes tested,
indicating that ROS contribute to their activation (Fig. 4A).
The effect of GSH on mTOR phosphorylation induced by
leucine at different time points was also determined. Phosphor-
ylation of mTOR in response to treatment with leucine presents
two peaks depending on the time of incubation with the amino
acid. Early activation of mTOR (5 min) is PI3K-independent,
while activation at later time points takes place through PI3K-
dependent mechanisms, since inhibitors like wortmannin can
prevent it [14]. Pretreatment of HSC with GSH abolished
mTOR phosphorylation induced by leucine at 5 and 30 min,
indicating that ROS accumulation is responsible for both PI3K
dependent and independent mTOR activation (Fig. 4B).
Fig. 5. Superoxide radical production in HSC treated with leucine. Intracellular
superoxide radical levels were measured by luminescence, using lucigenin as a
probe. HSC were incubated for 5 or 40 min with leucine 5 mM and luminescence
determined as described in Materials and methods. Each bar represents the mean±
SD of luminescence fold change compared to control of duplicate data from three
independent experiments (⁎⁎pb0.01, vs. control).
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In order to establish the mechanism(s) of oxidative stress
generation induced by leucine on HSC we determined the
intracellular levels of superoxide (O2·−), a ROS which is
characterized by its high reactivity and short life. In
physiological conditions, O2·− is metabolized to hydrogen
peroxide by the antioxidant enzyme superoxide dismutase
(SOD). We analyzed O2·− levels in intact HSC treated with
5 mM leucine for different time periods (5 to 40 min) using
lucigenin as a probe. As shown in Fig. 5, O2·− levels were
rapidly increased by leucine as compared to those of untreated
control cells.Fig. 6. Effect of rotenone and apocynin on intracellular ROS levels and mTOR phosph
rotenone (mitochondrial electron transfer complex I inhibitor) or 10 μM apocynin (NA
analyzed by fluorimetry using CM-H2DCFDA as a probe and treating HSC with leucine
change compared to control of quadruplicate data from three independent experimen
phosphorylation levels were analyzed by Western blot at 5 and 30 min of treatment withThe main sources of O2·− in the cell are the constitutive
NADPH oxidase complex, recently characterized in HSC [13],
and the mitochondria, mainly through the leakage of electrons in
electron chain complex III. The possible participation of
NADPH oxidase and mitochondria in ROS generation caused
by leucine was analyzed using rotenone, a compound that blocks
mitochondrial electron transfer in complex I, and apocynin, a
NADPH oxidase inhibitor. HSC were pretreated either with
rotenone 20 μM or apocynin 10 μM prior to the addition of
leucine 5 mM, and ROS levels determined as above at two
different time points, 5 and 40 min. Pretreatment with either
compound prevented intracellular ROS levels induced by
leucine, although apocynin was more effective at 5 min and
rotenone at later time periods (Fig. 6A).
To further confirm that ROS generated from the NADPH
oxidase system and mitochondria were involved in the signaling
events triggered by leucine, we analyzed the effects of apocynin
and rotenone on mTOR phosphorylation. Both rotenone and
apocynin partially abolishedmTORphosphorylation induced by
leucine at 5 and 40 min, as shown in Fig. 6B.
3.5. Role of IR/IGF- IR activation on the effects caused by
leucine on HSC
Since some of the signaling proteins activated by leucine in
this study are typically involved in the insulin and IGF-I
signaling pathways, we finally explored the possibility of IR/
IGF-IR being activated by ROS and mediating the effects of
leucine on HSC. Cells were treated with leucine 5 mM for 5 min
in the presence or absence of either rotenone or apocynin, andorylation induced by leucine. HSC were pretreated for 30 min with either 20 μM
DPH oxidase inhibitor) prior incubation with leucine 5 mM. (A) ROS levels were
5 mM for either 5 or 60 min. Each bar represents the mean±SD of fluorescence fold
ts (⁎pb0.05, ⁎⁎pb0.01; a, vs. control; b, vs. leucine-treated cells). (B) mTOR
leucine 5 mM. Data of mTOR phosphorylation fold change are included.
Fig. 7. IR/IGF-IR phosphorylation in HSC treated with leucine and pretreated
with rotenone or apocynin. HSC were pretreated for 30 min with 10 μM
apocynin (NADPH oxidase inhibitor), 20 μM rotenone (mitochondrial electron
transfer I inhibitor) or 2 mM glutathione, prior incubation with leucine 5 mM for
5 min. IR/IGF-IR phosphorylation levels were analyzed by Western blot.
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As shown in Fig. 7, incubation with leucine caused an enhance-
ment of the phosphorylation levels of these receptors.
Pretreatment with either rotenone or apocynin prevented IR/
IGF-IR phosphorylation, suggesting that ROS produced in
response to leucine were responsible for this effect.
4. Discussion
Oxidative stress is involved in the development of liver
fibrosis by different mechanisms, one of the most relevant being
the fibrogenic activity of hepatic stellate cells (HSC). Recent
evidence suggests that HSC are not only a target of reactive
oxygen species (ROS) produced by other cell types present in the
injured liver such as activated Kupffer cells or infiltrating
monocytes, but also contribute to oxidative stress through
increased ROS generation in response to cytokines like TGF-βFig. 8. Schematic representation of leucine effects in hepatic stellate cells. Leucine
increase of intracellular ROS levels. Phosphorylation of receptors for insulin and/or
induced by ROS. mTOR phosphorylates 4E-BP1 and as a consequence eIF4E is
phosphorylation by Mnk-1 also contributes to enhanced protein synthesis.or angiotensin II [5,10]. Since collagen production by HSC can
be modulated by ROS at transcriptional and post-transcriptional
levels, these data indicate that a positive regulatory loop with
ROS acting as mediators or co-activators could contribute to
fibrosis progression.
Our results demonstrate that leucine causes in HSC an
enhancement of intracellular ROS levels. To date, few reports
have described a relationship between leucine and oxidative
stress and the data are contradictory, probably because of the
different experimental approaches used. At high concentrations
(30.5 mM), leucine exerts in pancreatic islets a protective
antioxidant action similar to that of D-Glucose, due to its role as a
metabolic substrate [17]. However, there is also evidence of the
opposite effect: in cerebral cortex leucine causes oxidative stress
as a consequence of the inhibition of antioxidant enzymes like
catalase and GSH peroxidase and the oxidation of protein thiol
groups [18]. To our knowledge, the present study offers the first
evidence of ROS generation produced by leucine in a cell culture
system. The rapid increase in ROS levels detected in response to
leucine (5 min) ruled out transcriptional regulation of antioxi-
dant enzymes as being responsible for oxidative stress
generation, and suggested a direct activation of ROS production
through other mechanisms. Accordingly, we found that the
NADPH oxidase and mitochondrial electron transfer complexes
were involved in intracellular ROS levels enhancement by
leucine. The nonphagocytic NADPH oxidase has been recently
characterized in HSC as a mediator of fibrogenic responses [19].
Unlike the phagocytic form, the nonphagocytic NADPH oxidase
produces low basal levels of ROS that can be increased by
different stimuli. In cultured HSC reports of NADPH oxidase
activation caused by zinc deficiency [20], growth factors likeinduces O2·− production by NADPH oxidase and mitochondria, leading to an
IGF-I as well as activation of PI3K/Akt/mTOR and ERK signaling pathways is
released, allowing the formation of the translation initiation complex. eIF4E
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of apoptotic bodies [22] have been recently published. In all
cases, as well as in animal models in which the activity of the
enzymatic complex is enhanced [23], NADPH oxidase activa-
tion is related to the proliferation and/or increased fibrogenic
activity of HSC. Although little is known about mitochondrial
ROS production in HSC, a relationship between NADPH
oxidase and mitochondrial generation of ROS has been
suggested in other cell types and could also take place in our
system [24,25].
Increased ROS production caused by leucine mediated the
effects this amino acid on 4E-BP1 and eIF4E phosphorylation,
two translation regulatory steps that lead to enhanced collagen
type I production by HSC. Some reports found in the literature
show an inhibitory role for oxidative stress in the translational
machinery [26,27], but positive regulation by ROS through the
phosphorylation of eIF4E mediated by MAP kinases has also
been demonstrated [28]. This mechanism could explain some of
our results, since ERK, Mnk-1 and eIF4E phosphorylation
caused by incubation with leucine were prevented by GSH
pretreatment, pointing to a regulation of these proteins by ROS.
GSH also abrogated the phosphorylation of mTOR induced by
leucine at all the time points tested, showing that ROS modulate
both the PI3K-independent and PI3K-dependent activation of
mTOR that takes place at early and late incubation times,
respectively. Taking into account that ROS levels induced by
leucine were not altered by inhibition of any of the pathways
studied and that all the signaling steps analyzed in leucine-
treated HSC were ROS-dependent, the possibility of an up-
stream common mechanism could be suggested.
Early activated HSC express receptors for insulin and IGF-I
[29]. We investigated the possibility of IR/IGF-R mediating
leucine-induced effects because leucine and insulin/IGF-I
activate similar signaling pathways and both the insulin and
IGF-I receptors have been shown to be transactivated in
response to oxidative stress [2,30,31], probably through the
redox-dependent inhibition of protein phosphatase PTP1B [32].
We found that leucine caused an enhanced phosphorylation of
IR/IGF-IR at early time points of incubation and that both
rotenone and apocynin abolished IR/IGF-IR phosphorylation as
well as downstream signaling effects triggered by leucine such
as mTOR phosphorylation. These results suggest the following
sequence of events (Fig. 8): (1) intracellular ROS levels
produced by NADPH oxidase and mitochondrial electron
transfer complexes are increased in HSC by treatment with
leucine; (2) ROS accumulation induces the phosphorylation of
IR/IGF-IR and the activation of PI3K/Akt/mTOR and ERK
signaling pathways; (3) translational regulatory mechanisms are
modulated by PI3K/Akt/mTOR and ERK, finally leading to the
enhancement of collagen synthesis.
The role played by IR/IGF-IR as mediators of leucine-
induced responses could also explain a common effect described
for leucine and IGF-I on HSC: both agents stimulate the
production of hepatocyte growth factor (HGF) the main
mitogenic cytokine in hepatocytes and a key modulator for
liver function [33,34]. Interestingly, HGF has been shown to be
an antifibrogenic factor, due in part to the inhibition of TGF-βexpression by activated HSC [35]. In addition, IGF-1 has been
recently described to present antifibrogenic effects in animal
models for liver fibrosis [36,37] although in cell cultures of HSC
exerts a profibrogenic action [29]. These facts reflect the
complex network existing among cytokines and growth factors,
and suggest that leucine could cause different effects on HSC by
potentiating or counteracting the action of several agents
involved in fibrosis regulation. Further research would be
required to clarify the connections that appear to exist between
cytokines and nutritional factors, and their role in the regulation
of pathophysiological processes like liver fibrosis.Acknowledgements
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